Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 7/20 | 0.35 |
| ▸ | NFE2L2 | Q16236 | 7/20 | 0.35 |
| ▸ | CA1 | P00915 | 11/20 | 0.33 |
| ▸ | CA2 | P00918 | 11/20 | 0.33 |
| ▸ | CA4 | P22748 | 6/20 | 0.33 |
| ▸ | CA12 | O43570 | 4/20 | 0.33 |
| ▸ | CA9 | Q16790 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TERT | O14746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17897072 | 0.90 | CA1 (0.36) | CA1CA2CA4CA12CA9 | |
| SCHEMBL15161173 | 0.81 | CA1 (0.42) | CA1CA2CA4CA12CA9 | |
| SCHEMBL17897093 | 0.80 | KEAP1 (0.39) | KEAP1NFE2L2KDM4EALDH1A1HPGD | |
| SCHEMBL19234764 | 0.76 | TERT (0.43) | CA1CA2CA4CA12CA9 | |
| SCHEMBL17897081 | 0.73 | CA1 (0.39) | CA1CA2CA4CA12CA9 | |
| SCHEMBL15159292 | 0.73 | CA1 (0.42) | CA1CA2CA4CA12CA9 | |
| SCHEMBL19274958 | 0.70 | AR (0.35) | CA1CA2CA4CA12CA9 | |
| SCHEMBL17897078 | 0.67 | KDM4E (0.41) | CA1CA2CA4CA12CA9 | |
| SCHEMBL17897074 | 0.66 | KDM4E (0.41) | KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL15159301 | 0.66 | CA1 (0.38) | CA1CA2CA4CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9732378-B2 | Fluorophore chelated lanthanide luminescent probes with improved quantum efficiency | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2017-08-15 | — | — | US | disclosed |
| US-20160194690-A1 | FLUOROPHORE CHELATED LANTHANIDE LUMINESCENT PROBES WITH IMPROVED QUANTUM EFFICIENCY | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2016-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160194690-A1 | FLUOROPHORE CHELATED LANTHANIDE LUMINESCENT PROBES WITH IMPROVED QUANTUM EFFICIENCY | CLTA, LARS1, SSB | KEAP1 926/4885NFE2L2 3925/4885CA1 335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.